Gabriela R Oates1, Irena Stepanikova2, Stephanie Gamble3, Hector H Gutierrez4, William T Harris4. 1. Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 2. Department of Sociology, University of Alabama at Birmingham, Birmingham, Alabama. 3. Children's of Alabama, Birmingham, Alabama. 4. Division of Pediatric Pulmonology, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
OBJECTIVES: The evidence linking socioeconomic status (SES) and adherence in cystic fibrosis (CF) is inconclusive and focused on medication uptake. We examined associations between SES, adherence to airway clearance therapy (ACT), and CF respiratory outcomes. STUDY DESIGN: Socioeconomic, clinical, and adherence data of CF patients (N = 110) at a single CF Center were evaluated in this cross-sectional observational study. SES was operationalized as maternal and paternal education and household income. Adherence to ACT was measured with utilization data from the high-frequency chest wall oscillation (HFCWO) device over 4-6 weeks. Statistical modeling was used to test three hypotheses: (H1) Higher SES is associated with higher ACT adherence; (H2) Higher SES is associated with better respiratory outcomes; and (H3) ACT adherence mediates the relationship between SES and respiratory outcomes. RESULTS: In multinomial logistic regression, maternal college education, annual income >$50,000, and more adults in the household were independently related to better adherence (P < 0.05). Paternal college education, income >$100,000, and lack of exposure to smoking were independently related to higher lung function (P < 0.05). Current adherence to ACT with HFCWO was not associated with lung function over 12 months. CONCLUSIONS: SES is associated both with ACT adherence and respiratory outcomes in pediatric CF patients. However, the link between SES and respiratory outcomes in this study was not mediated by adherence to ACT with HFCWO. These data emphasize the importance of socioeconomic resources and household environment for CF health. Family socio-demographic profiles can help identify patients at increased risk for ACT nonadherence.
OBJECTIVES: The evidence linking socioeconomic status (SES) and adherence in cystic fibrosis (CF) is inconclusive and focused on medication uptake. We examined associations between SES, adherence to airway clearance therapy (ACT), and CF respiratory outcomes. STUDY DESIGN: Socioeconomic, clinical, and adherence data of CF patients (N = 110) at a single CF Center were evaluated in this cross-sectional observational study. SES was operationalized as maternal and paternal education and household income. Adherence to ACT was measured with utilization data from the high-frequency chest wall oscillation (HFCWO) device over 4-6 weeks. Statistical modeling was used to test three hypotheses: (H1) Higher SES is associated with higher ACT adherence; (H2) Higher SES is associated with better respiratory outcomes; and (H3) ACT adherence mediates the relationship between SES and respiratory outcomes. RESULTS: In multinomial logistic regression, maternal college education, annual income >$50,000, and more adults in the household were independently related to better adherence (P < 0.05). Paternal college education, income >$100,000, and lack of exposure to smoking were independently related to higher lung function (P < 0.05). Current adherence to ACT with HFCWO was not associated with lung function over 12 months. CONCLUSIONS: SES is associated both with ACT adherence and respiratory outcomes in pediatric CF patients. However, the link between SES and respiratory outcomes in this study was not mediated by adherence to ACT with HFCWO. These data emphasize the importance of socioeconomic resources and household environment for CF health. Family socio-demographic profiles can help identify patients at increased risk for ACT nonadherence.
Authors: Michael S Schechter; Susanna A McColley; Warren Regelmann; Stefanie J Millar; David J Pasta; Jeffrey S Wagener; Michael W Konstan; Wayne J Morgan Journal: J Pediatr Date: 2011-06-25 Impact factor: 4.406
Authors: David C Taylor-Robinson; Rosalind L Smyth; Peter J Diggle; Margaret Whitehead Journal: Lancet Respir Med Date: 2013-01-30 Impact factor: 30.700
Authors: Gabriela R Oates; Irena Stepanikova; Steven M Rowe; Stephanie Gamble; Hector H Gutierrez; William T Harris Journal: Respir Care Date: 2018-12-11 Impact factor: 2.258
Authors: Thida Ong; Michael Schechter; Jing Yang; Limin Peng; Julia Emerson; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld Journal: Pediatrics Date: 2017-01-16 Impact factor: 7.124
Authors: John E Pascoe; Hemant Sawnani; Oscar H Mayer; Keith McConnell; Joseph M McDonough; Cynthia White; Anne M Rutkowski; Raouf S Amin; Avani C Modi Journal: Pediatr Pulmonol Date: 2016-11-22
Authors: Lacrecia J Britton; Gabriela R Oates; Robert A Oster; Staci T Self; Robert B Troxler; Wynton C Hoover; Hector H Gutierrez; William T Harris Journal: Pediatr Pulmonol Date: 2016-08-24
Authors: Gabriela R Oates; Bryant W Hamby; Irena Stepanikova; Sara J Knight; Surya P Bhatt; Jason Hitchcock; Christopher Schumann; Mark T Dransfield Journal: COPD Date: 2017-10-11 Impact factor: 2.409
Authors: Gabriela R Oates; Elizabeth Baker; Steven M Rowe; Hector H Gutierrez; Michael S Schechter; Wayne Morgan; William T Harris Journal: J Cyst Fibros Date: 2020-02-17 Impact factor: 5.482
Authors: Edith T Zemanick; Thida Ong; Cori L Daines; Elisabeth P Dellon; Marianne S Muhlebach; Charles R Esther Journal: Pediatr Pulmonol Date: 2016-04-13